Terms: = Thyroid cancer AND FES, FPS, 2242, ENSG00000182511, P07332 AND Treatment
5 results:
1. Characterizing and forecasting neoantigens-resulting from MUC mutations in COAD.
Chen M; Zhang X; Ming Z; Lingyu ; Feng X; Han Z; An HX
J Transl Med; 2024 Mar; 22(1):315. PubMed ID: 38539235
[TBL] [Abstract] [Full Text] [Related]
2. Pregnancy outcomes in children, adolescents, and young adults that survived cancer: A nationwide survey in Japan.
Yasuoka T; Iwama N; Ota K; Harada M; Hasegawa J; Yaegashi N; Sugiyama T; Suzuki N; Osuga Y
J Obstet Gynaecol Res; 2021 Sep; 47(9):3352-3361. PubMed ID: 34155729
[TBL] [Abstract] [Full Text] [Related]
3. Personalized & Precision Medicine in cancer: A Theranostic Approach.
Choudhury P; Gupta M
Curr Radiopharm; 2017 Nov; 10(3):166-170. PubMed ID: 28758574
[TBL] [Abstract] [Full Text] [Related]
4. Vocal cord paresis following single-session high intensity focused ablation (HIFU) treatment of benign thyroid nodules: incidence and risk factors.
Lang BHH; Woo YC; Chiu KW
Int J Hyperthermia; 2017 Dec; 33(8):888-894. PubMed ID: 28540836
[TBL] [Abstract] [Full Text] [Related]
5. Are there any specific ultrasound findings of nodular hyperplasia ("leave me alone" lesion) to differentiate it from follicular adenoma?
Moon WJ; Kwag HJ; Na DG
Acta Radiol; 2009 May; 50(4):383-8. PubMed ID: 19241229
[TBL] [Abstract] [Full Text] [Related]
